Ophthalmos AS
Score · fiscal year 2025
69of 100
How to read this: the company is ahead of 88 % of companies in the Morning class Small in the same sector in 2025. What does this mean?
Rank in the Morning class Small: 40 of 336 · What are Morning company classes?
Place in the whole sector: 327 of 2,037 · Helse og omsorg
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 85 and solidity 86 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology
Against the sector
Ophthalmos AS is 18 points above the median for companies in the Morning class Small in the same sector in 2025.
Median score 51 among 336 companies.
Against companies in the Morning class Small in the same sector in 2025: operating margin 29.4% (median 5.0%) and equity ratio 79.4% (median 39.8%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 12 MNOK | 21 MNOK |
| Operating margin | 29.4% | 5.0% |
| Profit margin | 36.6% | 5.1% |
| Return on assets | 34.7% | 9.4% |
| Equity ratio | 79.4% | 39.8% |
| Debt-to-equity | 0.26 | 1.22 |
| Current ratio | 1.11 | 1.47 |
| Revenue growth | 0.6% | 4.9% |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 69, Ophthalmos AS does better than 88% of companies in the Morning class Small in the same sector (336 companies) in 2025.
Score 2023–2025
- Ophthalmos AS
- Median: companies in the Morning class Small in the same sector
Ophthalmos AS has a score of 69 for 2025, rank 327 of 2,037 in the sector.
Strongest: Solidity: percentile 86 against peers, equity ratio 79.4% against a median of 39.8%. Profitability: percentile 85 against peers, operating margin 29.4% against a median of 5.0%.
Weakest: Liquidity: percentile 30 against peers, current ratio 1.11 against a median of 1.47. Growth: percentile 31 against peers, revenue growth 0.6% against a median of 4.9%.
Worth a closer look
- What lies behind weak liquidity, and will it last?
- What lies behind weak growth, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Ophthalmos AS had an operating margin of 29.4% and an equity ratio of 79.4% in 2025, and ranks 327 of 2,037 in Helse og omsorg.
No large changes in the key figures from 2024 to 2025.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 10 MNOK and 36 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 36 MNOK |
| EV/EBIT | 8.0 | 31 MNOK |
| P/B | 1.0 | 10 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.1% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 85 | weight 30% |
|---|---|---|
| Solidity | 86 | weight 25% |
| Liquidity | 30 | weight 15% |
| Growth | 31 | weight 15% |
| Consistency | 82 | weight 15% |
Durability: 75 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Ophthalmos AS?
The operating margin was 29.4% in 2025, against a median of 5.0% among companies in the Morning class Small in the same sector. Return on assets was 34.7%.
How solid is Ophthalmos AS?
The equity ratio was 79.4% in 2025 (median 39.8%). Debt-to-equity was 0.26 (median 1.22).
What is the liquidity of Ophthalmos AS like?
The current ratio was 1.11 in 2025 (median 1.47).
How does Ophthalmos AS compare in Helse og omsorg?
Ophthalmos AS ranks 327 of 2,037 in Helse og omsorg for 2025. Among companies in the Morning class Small it is number 40 of 336. Revenue changed by 0.6% from the year before.
From the Central Coordinating Register
- Org. no.
- 912748162
- Legal form
- AS
- Sector
- Helse og omsorg (86.221)
- Morning company class
- Small
- Employees
- 0–4 (not registered)
- Founded
- 28 October 2013 13 years in operation
- Share capital
- 0.06 MNOK
- Business address
- Valkendorfsgaten 5, 5012 BERGEN
- Municipality
- Bergen rank 8 of 11 in KOSTRA group 12
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 2 November 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 30 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 84 | 71 | 69 | |
| Rank | 102 | 268 | 327 | |
| Operating margin | 28.5% | 31.1% | 29.4% | |
| Return on assets | 39.2% | 38.5% | 34.7% | |
| Equity ratio | 69.4% | 74.9% | 79.4% | |
| Current ratio | 2.78 | 1.65 | 1.11 | |
| Revenue growth | – | 3.9% | 0.6% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 11.6 MNOK | 12.0 MNOK | 12.1 MNOK |
| Operating profit | 3.3 MNOK | 3.7 MNOK | 3.5 MNOK |
| Profit before tax | 3.6 MNOK | 4.1 MNOK | 4.4 MNOK |
| Net profit | 2.8 MNOK | 3.2 MNOK | 3.6 MNOK |
| Financial expenses | 0.0 MNOK | 0.1 MNOK | 0.0 MNOK |
| Total assets | 9.2 MNOK | 10.7 MNOK | 12.7 MNOK |
| Current assets | 7.8 MNOK | 4.4 MNOK | 2.9 MNOK |
| Equity | 6.4 MNOK | 8.0 MNOK | 10.1 MNOK |
| Retained earnings | 6.3 MNOK | 8.0 MNOK | 10.1 MNOK |
| Total liabilities | 2.8 MNOK | 2.7 MNOK | 2.6 MNOK |
| Current liabilities | 2.8 MNOK | 2.7 MNOK | 2.6 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 30 October 2026, accounts id 6765620.
Further
Similar companies
- Elvebredden Tannlegesenter AS index 69, rank 323 · compare
- Rysteg AS index 68, rank 328 · compare
- Imed AS index 68, rank 331 · compare
- Sjøgløtt Omsorgssenter AS index 68, rank 337 · compare
- Melius Assistanse AS index 68, rank 340 · compare